Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 889120 | ISIN: US0352551081 | Ticker-Symbol: AKP
Frankfurt
27.06.25 | 08:00
9,250 Euro
-2,12 % -0,200
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ANIKA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
ANIKA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
9,0009,25019:03

Aktuelle News zur ANIKA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAktionäre von Anika Therapeutics genehmigen Änderung des Anreizplans und wählen Direktoren1
DiAnika Therapeutics, Inc. - 8-K, Current Report1
05.06.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)61BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early...
► Artikel lesen
12.05.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)98BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis ("OA") pain management and regenerative solutions spaces focused on...
► Artikel lesen
09.05.Anika Therapeutics, Inc. - 10-Q, Quarterly Report1
09.05.Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth1
09.05.Anika Q1 2025 slides: Commercial growth offset by OEM decline, guidance lowered6
ANIKA THERAPEUTICS Aktie jetzt für 0€ handeln
09.05.Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q11
09.05.Anika Therapeutics, Inc. - 8-K, Current Report1
09.05.Anika Therapeutics Inc.: Anika Reports First Quarter 2025 Financial Results404First Quarter 2025 Commercial Channel revenue up 18% Integrity Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones...
► Artikel lesen
09.05.Anika Therapeutics Non-GAAP EPS of -$0.06 misses by $0.15, revenue of $26.17M misses by $1.9M2
08.05.A Glimpse of Anika Therapeutics' Earnings Potential2
25.04.Anika Therapeutics Inc.: Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 20251
17.04.B.Riley sets Anika stock Buy rating, $21 target1
10.04.Anika Therapeutics, Inc. - 8-K, Current Report2
07.04.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)99BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis ("OA") Pain Management and Regenerative Solutions space focused on...
► Artikel lesen
12.03.Anika Therapeutics Non-GAAP EPS of -$0.03 misses by $0.12, revenue of $30.6M beats by $1.6M1
12.03.Anika Therapeutics Inc.: Anika Reports Fourth Quarter and Full Year 2024 Financial Results163Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40% sequential growth of Integrity Implant System drive...
► Artikel lesen
11.03.Anika Therapeutics, Inc. - 8-K, Current Report1
07.03.Anika Therapeutics Inc.: Anika Completes Divestiture of Parcus Medical155BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis Pain Management and Regenerative Solutions space focused on early...
► Artikel lesen
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1